GPS Wealth Strategies Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
GPS Wealth Strategies Group's EW Position: Q4 2025 in Review
GPS Wealth Strategies Group reduced its Edwards Lifesciences (EW) stake by 78% in Q4 2025, selling an estimated $450K and leaving 1,516 shares worth $129K. The position accounts for 0.11% of the portfolio, ranked #125.
GPS Wealth Strategies Group first reported a position in EW in Q3 2020 and has held it in 22 quarters since. The position peaked at $2M in Q4 2021. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.
- GPS Wealth Strategies Group held 1,516 shares of Edwards Lifesciences worth $129K as of Q4 2025.
- GPS Wealth Strategies Group sold 5,488 Edwards Lifesciences shares in Q4 2025, an estimated $450K.
- Edwards Lifesciences made up 0.11% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #125 holding.
- GPS Wealth Strategies Group first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 22 quarters since.
- GPS Wealth Strategies Group's Edwards Lifesciences position peaked at $2M in Q4 2021.
- 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.
Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.